These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21194593)

  • 21. Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility.
    Scheetz MH; Knechtel SA; Postelnick MJ; Malczynski M; Qi C
    Pharmacotherapy; 2010 Dec; 30(12):1221-8. PubMed ID: 21114389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.
    McKinnell JA; Patel M; Shirley RM; Kunz DF; Moser SA; Baddley JW
    Epidemiol Infect; 2011 Sep; 139(9):1342-50. PubMed ID: 21073764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
    Tamma PD; Hsu AJ
    Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.
    Balli EP; Venetis CA; Miyakis S
    Antimicrob Agents Chemother; 2014; 58(2):734-9. PubMed ID: 24247127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
    King ST; Usery JB; Holloway K; Koeth L; Cleveland KO; Gelfand MS
    J Antimicrob Chemother; 2011 Nov; 66(11):2673-5. PubMed ID: 21846674
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
    Melzer M; Goldsmith D; Gransden W
    Clin Infect Dis; 2000 Jul; 31(1):208-9. PubMed ID: 10913433
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia.
    McComb MN; Collins CD
    Pharmacotherapy; 2014 Jun; 34(6):537-44. PubMed ID: 24390863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with daptomycin: bacteraemia and endocarditis.
    Levine DP
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
    DiazGranados CA; Jernigan JA
    J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M; Wixson RL; Pertel PE
    Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
    Zeana C; Kubin CJ; Della-Latta P; Hammer SM
    Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
    Cunha BA; Mickail N; Eisenstein L
    Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
    Hayakawa K; Marchaim D; Pogue JM; Ho K; Parveen S; Nanjireddy P; Sunkara B; Singla M; Jagadeesh KK; Moshos JA; Bommarito S; Mroue R; Farhat M; Obeid T; Chaudhry A; Vadlamudi G; Lephart PR; Martin ET; Rybak MJ; Kaye KS
    Am J Infect Control; 2012 Dec; 40(10):e261-3. PubMed ID: 23199727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
    Hayakawa K; Martin ET; Gudur UM; Marchaim D; Dalle D; Alshabani K; Muppavarapu KS; Jaydev F; Bathina P; Sundaragiri PR; Rajuri SD; Khatri J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3968-75. PubMed ID: 24798267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.
    Twilla JD; Finch CK; Usery JB; Gelfand MS; Hudson JQ; Broyles JE
    J Hosp Med; 2012 Mar; 7(3):243-8. PubMed ID: 22076962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
    J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
    Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.